Adjuvant therapy in patients with ductal carcinoma in situ who undergo partial mastectomy remains controversial, particularly for low-risk patients (60 years or older, estrogen-positive, tumor extent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results